Seeking Alpha
 

Guggenheim S&P Equal Weight Health Care ETF (RYH)

- NYSEARCA
Show Summaries  |  Hide Summaries
  • Apr. 4, 2014, 1:12 PM
  • May 6, 2013, 1:36 PM
    Merck (MRK -1.3%) gets no love today from the FDA's approval of Liptruxet late Friday, as the stock is likely dragged down with the rest of the big pharma names on the back of a CNBC report that criticizes their earnings so far. The article points to the fact that pharmaceutical companies have seen a 4.7% contraction in earnings, and a 3.2% drop in revenue this quarter. Why? Morningstar's Damien Cover says there are two primary reasons: FX impact, especially from the yen, and intensified generic competition from patent losses.
    | Comment!
Visit Seeking Alpha's
RYH vs. ETF Alternatives
RYH Description
Seeks to replicate as closely as possible, before expenses, the performance of the S&P Equal Weight Index Health Care.
See more details on sponsor's website
Sector: Healthcare
Country: United States
ETF Hub
Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub